Suppr超能文献

常染色体显性遗传性多囊肾病的饮食干预。

Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

机构信息

Translational Medicine Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

Adv Nutr. 2022 Mar;13(2):652-666. doi: 10.1093/advances/nmab131. Epub 2023 Feb 10.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the progressive growth of renal cysts, leading to the loss of functional nephrons. Recommendations for individuals with ADPKD to maintain a healthy diet and lifestyle are largely similar to those for the general population. However, recent evidence from preclinical models suggests that more tightly specified dietary regimens, including caloric restriction, intermittent fasting, and ketogenic diets, hold promise to slow disease progression, and the results of ongoing human clinical trials are eagerly awaited. These dietary interventions directly influence nutrient signaling and substrate availability in the cystic kidney, while also conferring systemic metabolic benefits. The present review focuses on the importance of local and systemic metabolism in ADPKD and summarizes current evidence for dietary interventions to slow disease progression and improve quality of life.

摘要

常染色体显性多囊肾病(ADPKD)的特征是肾脏囊肿的进行性生长,导致功能性肾单位的丧失。对于 ADPKD 患者,建议保持健康的饮食和生活方式,这在很大程度上与一般人群相似。然而,来自临床前模型的最新证据表明,更严格的饮食方案,包括热量限制、间歇性禁食和生酮饮食,有望减缓疾病进展,人们急切地等待着正在进行的人体临床试验的结果。这些饮食干预直接影响囊性肾脏中的营养信号和底物可用性,同时也带来全身代谢益处。本综述重点关注局部和全身代谢在 ADPKD 中的重要性,并总结了目前关于饮食干预以减缓疾病进展和提高生活质量的证据。

相似文献

1
Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.
Adv Nutr. 2022 Mar;13(2):652-666. doi: 10.1093/advances/nmab131. Epub 2023 Feb 10.
3
Polycystic Kidney Disease Diet: What is Known and What is Safe.
Clin J Am Soc Nephrol. 2024 May 1;19(5):664-682. doi: 10.2215/CJN.0000000000000326. Epub 2023 Sep 20.
4
Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.
Clin J Am Soc Nephrol. 2020 Apr 7;15(4):577-584. doi: 10.2215/CJN.13291019. Epub 2020 Feb 21.
8
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't.
Clin Kidney J. 2022 Apr 21;15(6):1034-1036. doi: 10.1093/ckj/sfac103. eCollection 2022 Jun.
9
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Nephrol Dial Transplant. 2023 Jun 30;38(7):1623-1635. doi: 10.1093/ndt/gfac311.
10
Is autosomal dominant polycystic kidney disease an early sweet disease?
Pediatr Nephrol. 2022 Sep;37(9):1945-1955. doi: 10.1007/s00467-021-05406-z. Epub 2022 Jan 5.

引用本文的文献

4
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients.
Clin Kidney J. 2023 Jul 18;16(12):2309-2313. doi: 10.1093/ckj/sfad176. eCollection 2023 Dec.
5
Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease.
Adv Kidney Dis Health. 2023 May;30(3):220-227. doi: 10.1053/j.akdh.2022.12.008.
6
Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.
Front Mol Biosci. 2022 Aug 23;9:962933. doi: 10.3389/fmolb.2022.962933. eCollection 2022.
8
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't.
Clin Kidney J. 2022 Apr 21;15(6):1034-1036. doi: 10.1093/ckj/sfac103. eCollection 2022 Jun.
9
Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.
Kidney Dial. 2022 Mar;2(1):106-122. doi: 10.3390/kidneydial2010013. Epub 2022 Mar 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验